Gastric sleeve and RYGB have been reported to significantly improve hepatic insulin sensitivity [18] and liver function in obesity-related NAFLD [19] and represent potential therapeutic strategies for NAFLD treatment [20,21]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.